Bryan A. Faller
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 7
- Lung Cancer Research Studies 7
- Colorectal Cancer Treatments and Studies 3
- Cancer Treatment and Pharmacology 3
- Neutropenia and Cancer Infections 3
- Geriatrics and Gerontology top 10%
-
- Lung Cancer Treatments and Mutations 9
- Lung Cancer Diagnosis and Treatment 8
-
- Melanoma and MAPK Pathways 3
- Co-authors
- Barbara BurtnessKaren KellyMary W. RedmanKaren L. ReckampDavid R. GandaraJhanelle E. GraySaiama N. WaqarTareq Al Baghdadi
- Journals
- Journal of Clinical Oncology (15 papers)Journal of the National Comprehensive Cancer Network (2 papers)Clinical Lung Cancer (2 papers)
- Partner nations
- United StatesIrelandIndia
In The Last Decade
Bryan A. Faller
30 papers receiving 527 citations
Hit Papers
Peers
Comparison fields: 5 of 71
- Oncology 325
- Geriatrics and Gerontology 30
- Cancer Research 83
- Pulmonary and Respiratory Medicine 179
- Family Practice 11
Countries citing papers authored by Bryan A. Faller
This map shows the geographic impact of Bryan A. Faller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan A. Faller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan A. Faller more than expected).
Fields of papers citing papers by Bryan A. Faller
This network shows the impact of papers produced by Bryan A. Faller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan A. Faller. The network helps show where Bryan A. Faller may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bryan A. Faller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 30 | |
| 4 | 2024 | 12 | |
| 5 | 2023 | 15 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 3 | |
| 8 | Phase II Randomized Study of Ramucirumab and Pembrolizumab Versus Standard of Care in Advanced Non–Small-Cell Lung Cancer Previously Treated With Immunotherapy—Lung-MAP S1800Abreakdown → | 2022 | 128 |
| 9 | 2021 | 76 | |
| 10 | 2021 | 17 | |
| 11 | 2021 | 27 | |
| 12 | 2021 | 2 | |
| 13 | 2020 | 67 | |
| 14 | 2020 | 0 | |
| 15 | 2020 | 4 | |
| 16 | 2016 | 7 | |
| 17 | 2009 | 26 | |
| 18 | 2009 | 7 | |
| 19 | 2008 | 3 | |
| 20 | 2008 | 2 |
About Bryan A. Faller
Bryan A. Faller is a scholar working on Oncology, Geriatrics and Gerontology and Pulmonary and Respiratory Medicine, having authored 32 papers that have together received 532 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Diagnosis and Treatment (8 papers), Cancer Immunotherapy and Biomarkers (7 papers), Lung Cancer Research Studies (7 papers), Colorectal Cancer Treatments and Studies (3 papers), Cancer Treatment and Pharmacology (3 papers), Melanoma and MAPK Pathways (3 papers) and Neutropenia and Cancer Infections (3 papers). The work is most often cited by research in Oncology (325 citations), Geriatrics and Gerontology (30 citations) and Cancer Research (83 citations). Bryan A. Faller has collaborated with scholars based in United States, Ireland and India. Frequent co-authors include Barbara Burtness, Karen Kelly, Mary W. Redman, Karen L. Reckamp, David R. Gandara, Jhanelle E. Gray, Saiama N. Waqar, Tareq Al Baghdadi, Roy S. Herbst and Katherine Minichiello. Their work appears in journals such as Journal of Clinical Oncology, Journal of the National Comprehensive Cancer Network, Clinical Lung Cancer, Cancer Research and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.